MARK BELILL: Open Payments
NPI 1528604956 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 24 payments from 7 companies in 2025. Trend: 2023 $654 · 2024 $234 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $372 |
| Boston Scientific Corporation | 1 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| SCPHARMACEUTICALS INC. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: FARXIGA, WATCHMAN, LOKELMA, JARDIANCE, FUROSCIX, Kerendia, VERQUVO, VYNDAQEL.
Industry payments across NM — which companies pay providers there.
